DUPIXENT is indicated as an add-on maintenance treatment in adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP).¹

Some examples of CRSwNP patients who may be appropriate for DUPIXENT are¹:

• Patients who are uncontrolled despite use of SCS and previous sinus surgery
• Patients who are surgery naive
• Patients with a history of asthma
• Patients with comorbid NSAID-ERD

NSAID-ERD, nonsteroidal anti-inflammatory drug–exacerbated respiratory disease; SCS, systemic corticosteroids.